{"schema_version":"secwatch.filing_event.v1","accession":"0000105418-26-000037","form_type":"8-K","ticker":"WMK","cik":"0000105418","company_name":"WEIS MARKETS INC","filed_at":"2026-05-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:31.879568+00:00","generated_at":"2026-05-14T22:27:10.212736+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Weis Markets Q1 revenue up 4.6% to $1.26B; net income jumps 42.5% to $27.85M","bullets":["Total revenue $1.26B vs $1.20B (+4.6%); comp store sales ex-fuel +1.2% YoY, +2.2% two-year stacked.","Net income $27.85M vs $19.55M (+42.5%); diluted EPS $1.13 vs $0.73.","Pharmacy revenue hurt by ~$7.48M from Inflation Reduction Act MFP provisions effective Jan 1, 2026.","Quarterly dividend $0.34/share, payable May 26, 2026 to shareholders of record May 11, 2026.","CEO highlights record 2025 capex: 5 new stores, 7 remodels, 5 fuel centers, 1,000+ smaller projects."],"urls":{"canonical":"https://secwatch.observer/filing/0000105418-26-000037","json":"https://secwatch.observer/filing/0000105418-26-000037.json","markdown":"https://secwatch.observer/filing/0000105418-26-000037.md","text":"https://secwatch.observer/filing/0000105418-26-000037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/105418/000010541826000037/0000105418-26-000037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/105418/000010541826000037/wmk-20260506x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T22:27:10.212736+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"340ba4b9fd758b4bca70e5b14826e712e59e6eb5","claim":"WEIS MARKETS INC reported first quarter ended March 28, 2026 results: revenue $1.26 billion, net income $27.85 million, EPS $1.13.","evidence_excerpt":"in the first quarter. We are grateful to our associates, whose hard work makes these solid results possible,” said Mr. Weis. ​ First Quarter 2026 Results ​ Total revenue was $1.26 billion for the 13-week first quarter ended March 28, 2026, compared to $1.20 billion for the same period in 2025, a 4.6% increase. Pharmacy revenue growth was unfavorably impacted by","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/105418/000010541826000037/0000105418-26-000037-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001104659-26-069227","ticker":"YSWY","company_name":"Yesway, Inc.","filed_at":"2026-06-02T11:35:47+00:00","headline":"Yesway reports Q1 net income $30.2M, Adjusted EBITDA $59.2M; introduces FY2026 outlook","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-069227","json":"https://secwatch.observer/filing/0001104659-26-069227.json","markdown":"https://secwatch.observer/filing/0001104659-26-069227.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859836/000110465926069227/0001104659-26-069227-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859836/000110465926069227/tm2616553d1_8k.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"in the first quarter. We are grateful to our associates, whose hard work makes these solid results possible,” said Mr. Weis. ​ First Quarter 2026 Results ​ Total revenue was $1.26 billion for the 13-week first quarter ended March 28, 2026, compared to $1.20 billion for the same period in 2025, a 4.6% increase. Pharmacy revenue growth was unfavorably impacted by","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/105418/000010541826000037/0000105418-26-000037-index.htm","comparable_excerpt":"On June 2, 2026, Yesway, Inc. issued a press release announcing its financial results for the three months ended March 31, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1859836/000110465926069227/0001104659-26-069227-index.htm"}},{"accession":"0001856437-26-000011","ticker":"VSCO","company_name":"Victoria's Secret & Co.","filed_at":"2026-06-02T11:01:54+00:00","headline":"Victoria's Secret Q1 sales up 15% to $1.56B, beats guidance; raises FY2026 outlook","event_type":"earnings","sec_items":["2.02","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001856437-26-000011","json":"https://secwatch.observer/filing/0001856437-26-000011.json","markdown":"https://secwatch.observer/filing/0001856437-26-000011.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1856437/000185643726000011/0001856437-26-000011-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1856437/000185643726000011/vsco-20260602.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"in the first quarter. We are grateful to our associates, whose hard work makes these solid results possible,” said Mr. Weis. ​ First Quarter 2026 Results ​ Total revenue was $1.26 billion for the 13-week first quarter ended March 28, 2026, compared to $1.20 billion for the same period in 2025, a 4.6% increase. Pharmacy revenue growth was unfavorably impacted by","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/105418/000010541826000037/0000105418-26-000037-index.htm","comparable_excerpt":"The Company reported net sales of $1.560 billion for the first quarter of 2026, an increase of 15% compared to net sales of $1.353 billion for the first quarter of 2025 and above the previously communicated guidance range of $1.490 billion to $1.525 billion. Total comparable sales for the first quarter of 2026 increased 13%. The Company reported operating income for the first quarter of 2026 of $76 million compared to operating income of $20 million in the first quarter of 2025. Net income was $48 million, or $0.56 per diluted share, for the first quarter of 2026 compared to net loss of $2 million, or $0.02 per diluted share, for the first quarter of 2025.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1856437/000185643726000011/0001856437-26-000011-index.htm"}},{"accession":"0001104659-26-069202","ticker":"CTRN","company_name":"Citi Trends Inc","filed_at":"2026-06-02T10:58:00+00:00","headline":"Citi Trends Q1 sales up 14.4% to $230.9M; adjusted EBITDA doubles to $13.9M","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-069202","json":"https://secwatch.observer/filing/0001104659-26-069202.json","markdown":"https://secwatch.observer/filing/0001104659-26-069202.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1318484/000110465926069202/0001104659-26-069202-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1318484/000110465926069202/tm2616574d1_8k.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"in the first quarter. We are grateful to our associates, whose hard work makes these solid results possible,” said Mr. Weis. ​ First Quarter 2026 Results ​ Total revenue was $1.26 billion for the 13-week first quarter ended March 28, 2026, compared to $1.20 billion for the same period in 2025, a 4.6% increase. Pharmacy revenue growth was unfavorably impacted by","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/105418/000010541826000037/0000105418-26-000037-index.htm","comparable_excerpt":"(EXHIBIT 99.1) ---\n\nEX-99.1 2 tm2616574d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 CITITRENDS ANNOUNCES FIRST QUARTER\nFISCAL 2026 RESULTS Q1 2026 total sales increased 14.4% to $230.9 million Comparable store sales growth\nof 13.9%; Two-year stack of 23.8% Q1 2026 Net Income of $7.8 million;\nQ1 2026 adjusted EBITDA* of $13.9 million, more than double Q1 2025 results","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1318484/000110465926069202/0001104659-26-069202-index.htm"}},{"accession":"0000832988-26-000158","ticker":"SIG","company_name":"SIGNET JEWELERS LTD","filed_at":"2026-06-02T10:54:29+00:00","headline":"Signet Q1 sales $1.6B, SSS +1.8%; raises FY27 adjusted EPS guidance","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000832988-26-000158","json":"https://secwatch.observer/filing/0000832988-26-000158.json","markdown":"https://secwatch.observer/filing/0000832988-26-000158.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/832988/000083298826000158/0000832988-26-000158-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/832988/000083298826000158/sig-20260602.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"in the first quarter. We are grateful to our associates, whose hard work makes these solid results possible,” said Mr. Weis. ​ First Quarter 2026 Results ​ Total revenue was $1.26 billion for the 13-week first quarter ended March 28, 2026, compared to $1.20 billion for the same period in 2025, a 4.6% increase. Pharmacy revenue growth was unfavorably impacted by","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/105418/000010541826000037/0000105418-26-000037-index.htm","comparable_excerpt":"On June 2, 2026, Signet Jewelers Limited (the \"Company\") issued a press release announcing results for the first quarter ended May 2, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/832988/000083298826000158/0000832988-26-000158-index.htm"}},{"accession":"0001104659-26-069198","ticker":"DG","company_name":"DOLLAR GENERAL CORP","filed_at":"2026-06-02T10:54:17+00:00","headline":"Dollar General Q1 EPS $2.00 beats expectations; raises FY2026 EPS guidance","event_type":"earnings","sec_items":["2.02","5.07","7.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-069198","json":"https://secwatch.observer/filing/0001104659-26-069198.json","markdown":"https://secwatch.observer/filing/0001104659-26-069198.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/29534/000110465926069198/0001104659-26-069198-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/29534/000110465926069198/tm2616084d1_8k.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"in the first quarter. We are grateful to our associates, whose hard work makes these solid results possible,” said Mr. Weis. ​ First Quarter 2026 Results ​ Total revenue was $1.26 billion for the 13-week first quarter ended March 28, 2026, compared to $1.20 billion for the same period in 2025, a 4.6% increase. Pharmacy revenue growth was unfavorably impacted by","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/105418/000010541826000037/0000105418-26-000037-index.htm","comparable_excerpt":"(NYSE: DG) today reported financial results for its first quarter (13 weeks) ended May 1, 2026. First Quarter Fiscal Year 2026\nHighlights · Net\n Sales Increased 3.4% to $10.8 Billion · Same-Store\n Sales Increased 2.0% · Operating\n Profit Increased 10.8% to $638.5 Million · Diluted\n Earnings Per Share (“EPS”) Increased 12.4% to $2.00 · Cash\n Flow From","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/29534/000110465926069198/0001104659-26-069198-index.htm"}},{"accession":"0001062993-26-002965","ticker":"HIVE","company_name":"HIVE Digital Technologies Ltd.","filed_at":"2026-06-02T10:23:19+00:00","headline":"HIVE FY2026 revenue $297.8M (+158% YoY); GAAP net loss $148.4M","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-26-002965","json":"https://secwatch.observer/filing/0001062993-26-002965.json","markdown":"https://secwatch.observer/filing/0001062993-26-002965.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1720424/000106299326002965/0001062993-26-002965-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1720424/000106299326002965/form8k.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"in the first quarter. We are grateful to our associates, whose hard work makes these solid results possible,” said Mr. Weis. ​ First Quarter 2026 Results ​ Total revenue was $1.26 billion for the 13-week first quarter ended March 28, 2026, compared to $1.20 billion for the same period in 2025, a 4.6% increase. Pharmacy revenue growth was unfavorably impacted by","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/105418/000010541826000037/0000105418-26-000037-index.htm","comparable_excerpt":"EXHIBIT 99.1 HIVE Digital Technologies Ltd.: Exhibit 99.1 - Filed by newsfilecorp.com Exhibit 99.1 HIVE DIGITAL TECHNOLOGIES LTD. HIVE Achieves FY2026 Total Revenue of $297.8 Million (+158% YoY), HIVE's BUZZ HPC Positioned for Growth This news release constitutes a \"designated news release\" for the purposes of the Company's prospectus supplement dated","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1720424/000106299326002965/0001062993-26-002965-index.htm"}},{"accession":"0000029644-26-000049","ticker":"DCI","company_name":"DONALDSON Co INC","filed_at":"2026-06-01T21:41:36+00:00","headline":"Donaldson Q3 FY2026 sales $995.1M (+5.8%), adj. EPS $1.06 (+7.1%)","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000029644-26-000049","json":"https://secwatch.observer/filing/0000029644-26-000049.json","markdown":"https://secwatch.observer/filing/0000029644-26-000049.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/29644/000002964426000049/0000029644-26-000049-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/29644/000002964426000049/dci-20260602.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"in the first quarter. We are grateful to our associates, whose hard work makes these solid results possible,” said Mr. Weis. ​ First Quarter 2026 Results ​ Total revenue was $1.26 billion for the 13-week first quarter ended March 28, 2026, compared to $1.20 billion for the same period in 2025, a 4.6% increase. Pharmacy revenue growth was unfavorably impacted by","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/105418/000010541826000037/0000105418-26-000037-index.htm","comparable_excerpt":"press release is furnished herewith as Exhibit 99.1. \n\n--- EX-99.1 (EX-99.1) ---\n\nDonaldson Reports Record Third Quarter Fiscal 2026 Sales and Earnings Third quarter sales of $995.1 million, up 5.8% Operating margin of 15.6%; All-time high adjusted operating margin of 16.6% GAAP EPS of $1.00; Adjusted EPS of $1.06, up 7.1% Closed margin-accretive Facet acquisition,","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/29644/000002964426000049/0000029644-26-000049-index.htm"}},{"accession":"0001104659-26-068983","ticker":"GMRS","company_name":"GMR Solutions Inc.","filed_at":"2026-06-01T20:45:55+00:00","headline":"GMR Solutions Q1 revenue $1.46B (+6.6% YoY), net income $106M (+180% YoY), guides FY26 rev $5.9-6.2B","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-068983","json":"https://secwatch.observer/filing/0001104659-26-068983.json","markdown":"https://secwatch.observer/filing/0001104659-26-068983.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1898718/000110465926068983/0001104659-26-068983-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1898718/000110465926068983/gmrs-20260601x8k.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"in the first quarter. We are grateful to our associates, whose hard work makes these solid results possible,” said Mr. Weis. ​ First Quarter 2026 Results ​ Total revenue was $1.26 billion for the 13-week first quarter ended March 28, 2026, compared to $1.20 billion for the same period in 2025, a 4.6% increase. Pharmacy revenue growth was unfavorably impacted by","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/105418/000010541826000037/0000105418-26-000037-index.htm","comparable_excerpt":"today announced financial results for the first quarter ended March 31, 2026, and full year 2026 financial guidance. First Quarter 2026 Financial Highlights ● Net revenue of $1,457.6 million, up 6.6% compared to $1,367.4 million in the first quarter of 2025 ● Net income of $106.3 million, up 179.7% compared to $38.0 million in the first quarter of 2025 ● Adjusted","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1898718/000110465926068983/0001104659-26-068983-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}